Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham et al. · JNCI Journal of the National Cancer Institute · 1998 · 5.5K citations · Full text

Medicine, Oncology, Preventive Medicine +15

Breast cancer and hormone-replacement therapy in the Million Women Study

Valerie Beral · The Lancet · 2003 · 3K citations

Medicine, Endocrinology, Oncology +13

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

M Baum, Aman U. Budzar, J Cuzick et al. · The Lancet · 2002 · 2K citations

Pharmacy, Oncology, Pharmacotherapy +13

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial

R P Kedar, T. Bourne, W. P. Collins et al. · The Lancet · 1994 · 539 citations

Medicine, Gynecology, Oncology +8